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Abstract
Background: Earlier studies in nursing homes show a high prevalence of cognitive impairment, dependency in
activities of daily living (ADL), pain, and neuropsychiatric symptoms among residents. The aim of this study was to
explore the prevalence of the above among residents in a nationally representative sample of Swedish nursing
homes, and to investigate whether pain and neuropsychiatric symptoms differ in relation to gender, cognitive
function, ADL-capacity, type of nursing-home unit and length of stay.
Methods: Cross-sectional data from 188 randomly selected nursing homes were collected. A total of 4831 residents
were assessed for cognitive and ADL function, pain and neuropsychiatric symptoms. Data were analysed using
descriptive statistics and the chi-square test.
Results: The results show the following: the prevalence of cognitive impairment was 67 %, 56 % of residents were
ADL-dependent, 48 % exhibited pain and 92 % exhibited neuropsychiatric symptoms. The prevalence of pain did
not differ significantly between male and female residents, but pain was more prevalent among cognitively impaired
and ADL-dependent residents. Pain prevalence was not significantly different between residents in special care units
for people with dementia (SCU) and general units, or between shorter-and longer-stay residents. Furthermore, the
prevalence of neuropsychiatric symptoms did not differ significantly between male and female residents, between ADL
capacities or in relation to length of stay. However, residents with cognitive impairment and residents in SCUs had a
significantly higher prevalence of neuropsychiatric symptoms than residents without cognitive impairment and
residents in general units.
Conclusions: The prevalence rates ascertained in this study could contribute to a greater understanding of the needs
of nursing-home residents, and may provide nursing home staff and managers with trustworthy assessment scales and
benchmark values for further quality assessment purposes, clinical development work and initiating future nursing
assessments.
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Background
The provision of nursing-home care is a public service
in Sweden, and nursing homes are individual, means-
tested accommodation units provided by the municipal-
ities for people who need full-time care. To be eligible
for admission to a nursing home, the person needs ex-
tensive help in managing daily living due to age, illness
and/or disability. Cognitive and physical impairments
are two of the factors most associated with nursing-
home admission [1] and both cognitive and ADL impair-
ments have been shown to be common in nursing
homes internationally [2–5]. Two previous studies in
Sweden show that cognitive impairment among nursing-
home residents was prevalent in 71 % (2008) [6] and
73 % (2013) [7] respectively of all cases. However, these
studies were limited because of their regional context
and, in the case of the first one, also regarding their
sample size (n = 315). Studies in similar settings from
other countries indicate rates ranging from 59 % (2009)
[2] to 68 % [3] and as high as 80 % (2004/2005) [4].
Among US nursing-home residents, only 11.0 % (2012)
were reported to have little or no cognitive impairment
and no ADL impairment [5]. In a European study (2009–
2011) in eight countries (the Czech Republic, England,
Finland, France, Germany, Italy, The Netherlands and
Israel) including approximately 500 residents from each
country, 81 % of nursing-home residents are described as
needing assistance or dependent in ADL. The study used
the seven point MDS Activities of Daily Living Hierarchy
scale [8] to measure ADL, where a score of 2–4 indicates
ADL assistance, and a score of ≥ 5 being dependent in
ADL [3]. Although the study by Onder et al. had a large
sample it was not randomized.
Previous studies also show pain to be a prevalent
symptom among older people in nursing homes and
similar settings [9–12]. A Swedish cross-sectional study
(2000) reported a pain prevalence of 57 % among resi-
dents in nursing homes [11]. Results from the European
study (2009–2011) of eight countries (excluding Sweden)
show a prevalence of pain ranging from 20 % (Israel) to
78 % (Finland) [12] and a review of 27 studies (1990 to
2009) finds pain to be common among residents but the
prevalence varied from 4 to 80 % among the different
studies. The highest rates were found when pain was
self-reported, around 60–70 %, with a range of 28 to
80 %. The prevalence of pain varied from 4 to 64 %
when information was collected by means of chart re-
view or data from the MDS database. When mixed
methods were used, such as interview together with ob-
servation, the prevalence rates were around 40–60 % [9].
Differences in the prevalence of pain and its association
with gender, cognitive impairment, ADL capacity and type
of unit have also been described. The prevalence of pain
was found to be higher among female residents [13, 14].
Pain has been positively associated with female gender
and negatively associated with dementia and severe cogni-
tive impairment [10, 15]. No differences in prevalence
were seen between residents with and without cognitive
impairment in the Swedish study [11]. Additionally, in a
US study with a sample of 13 107 nursing-home residents,
residents in special care units for people with dementia
(SCU) were found to have less pain than residents in regu-
lar units [16].
Exhibiting neuropsychiatric symptoms is another leading
cause for admission to a nursing home [17]. Neuropsychi-
atric symptoms have a multifactorial aetiology which in-
cludes disease-related neuropathological changes, unmet
physical or psychological needs, environmental influence
and/or pain [18]. A review of studies (1987 to 2012) from
Spain, The Netherlands, Finland, Austria, the UK, USA,
Korea, Japan Taiwan, and Australia indicates that the
prevalence of one or more neuropsychiatric symptoms
ranged from 38–95 % in nursing-home residents with de-
mentia [19]. A Dutch study (2011) shows a prevalence of
89 % among residents in SCUs [20], and male residents
with dementia are described as exhibiting more neuro-
psychiatric symptoms [21, 22]. Neuropsychiatric symp-
toms are also described as being associated with impaired
ADL function [23].
As illustrated in the above studies, the prevalence of
cognitive impairment, pain and neuropsychiatric symp-
toms varies among countries and contexts, and prevalence
rates also seem to vary among resident characteristics
such as gender, cognitive impairment, and ADL impair-
ment, as well as type of unit. The prevalence of pain seems
to be higher among female residents and lower among
residents with cognitive impairment, even though conflict-
ing results exist [11]. This indicates a need to further study
the prevalence and variance in prevalence rates on na-
tional levels. There seems to be a shortage of national ran-
domized population-based studies on the prevalence of
these symptoms. Cross-sectional data have been collected
from nursing-home residents in Nordic countries, but
limited to residents in the four capitals of Denmark,
Finland, Iceland and Sweden, as well as at a European
level [3, 10, 12] but since Sweden has no national repeated
measures of health and health-related factors for the na-
tional population of residents in nursing homes as other
countries have, comparison of studies is difficult. Large [7,
11] and smaller [6, 24] studies have been performed in
Swedish nursing homes, but to our knowledge no national
study of the prevalence of cognitive impairment, pain and
neuropsychiatric symptoms among residents in nursing
homes has been reported. Knowledge about national
prevalence rates would provide a point of reference that
could be of great value for other future national and inter-
national studies, allowing comparisons of their result with
these results. National evaluation of residents’ needs and
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capabilities would help in questions of financing and the
planning of care on a national level, and thus also be of
value to stakeholders and organizations. Knowledge about
national prevalence rates could contribute to a greater un-
derstanding of nursing-home residents’ needs, and would
provide nursing-home staff and researchers with the start-
ing point for future nursing assessments.
The aim of this study was, therefore, to explore the
prevalence of cognitive impairment, ADL-dependency,
pain and neuropsychiatric symptoms among residents in
a nationally representative Swedish sample, and to inves-
tigate whether pain and neuropsychiatric symptoms
differ in relation to gender, cognitive function, ADL-
capacity, type of unit and length of stay.
The following research questions were explored:
 What is the prevalence of cognitive impairment,
ADL-dependency, pain and neuropsychiatric
symptoms among older people in Swedish
nursing homes?
 Does the prevalence of pain and neuropsychiatric
symptoms differ in relation to gender, cognitive
function, ADL-capacity, type of unit and length
of stay?
Methods
Design, sampling and participants
The data for the analyses in this study were drawn from
the cross-sectional baseline data set from the Swedish
National Inventory of Health and Care in Nursing
Homes (SVENIS) [25], longitudinal studies are planned
with the next one to be conducted in 2018. Data were
collected between November 2013 and September 2014.
From a randomly selected sample of 60 of the 290 Swed-
ish municipalities, 38 agreed to participate in the study.
In these 38 municipalities, 194 nursing-home facilities
were contacted about participation, and all but six agreed.
Unit managers were contacted by telephone, given infor-
mation about the study and sent questionnaires. These
were then distributed to staff who conducted all assess-
ments of residents. Only residents permanently living in
the participating nursing homes were included in the
study. Hence, residents subject to short-term or tempor-
ary arrangements were excluded. Staff members were pro-
vided with written information about the study and with
instructions on how to carry out the assessments. No per-
sonal identification of the individual residents or staff was
collected.
Data collection
Unit managers informed the staff about the study. The
member of staff who knew each individual resident best
was asked to perform the proxy ratings, based on his/
her professional assessment of the individual resident.
Instrumentation
Cognitive function was assessed using the Gottfries’ cog-
nitive scale, consisting of 27 items, intended to measure
a person’s level of cognitive function [26]. Items are for-
mulated as statements answered with a ‘yes’ (1) or ‘no’
(0), and higher scores indicate a higher cognitive func-
tion. Scores lower than 24 indicate cognitive impair-
ment. Internal consistency was found to be satisfactory
in the dataset with a Cronbach’s alpha of 0.96. Criterion-
related validity of the cut-off of the scale has been estab-
lished against the Mini-Mental State Examination [27].
ADL capacity was measured using a modified version of
the Katz Index of Independence in Activities of Daily Liv-
ing [28]. The scale assesses the ability to independently
manage daily activities in the following six personal ADL
domains: bathing, dressing, transferring, toileting, eating,
and continence. Each domain was scored dichotomously
as dependent ‘0’ versus fully independent ‵1′, giving a total
score of 0–6 points. Higher scores indicate greater inde-
pendence. Internal consistency was satisfactory in the
dataset as evidenced by a Cronbach’s alpha of 0.86.
Pain was investigated using the Pain Assessment in
Advanced Dementia (PAINAD) scale, which evaluates
symptoms of pain based on breathing, body language, fa-
cial expression, vocalization, and consolability. Each of
the five items is scored between 0 and 2, giving a total
score of 0–10 points; higher scores indicate greater pain
intensity [29]. Criterion validity has been reported as sat-
isfactory [30] internal consistency values of 0.5–0.65
have been reported [29]. A Swedish version of the in-
strument was available, but no published data on validity
were found. PAINAD has also been tested in hospital-
ized cognitively intact and impaired post-orthopaedic
surgical older adults and a positive correlation was
found between a self-report pain scale and the PAINAD
[31]. The internal consistency was satisfactory in the
dataset as evidenced by a Cronbach’s alpha of 0.75.
The prevalence of neuropsychiatric symptoms was
assessed using the Neuropsychiatric Inventory—Nursing
Home Version (NPI-NH). The NPI-NH evaluates the fol-
lowing 12 neuropsychiatric symptoms: delusions, hallucina-
tions, agitation/aggression, depression/dysphoria, anxiety,
elation/euphoria, apathy, disinhibition, irritability/lability,
aberrant motor behaviours, night-time behaviours, and eat-
ing behaviours. Each symptom is rated from not occurring
at all (a score of 0) to occurring several times per day (a
score of 4). The NPI-NH has previously been found to be
valid and reliable [32], for example in a Norwegian version
with high inter-rater reliability values (inter-rater reliability
between 0.85 and 1.0, across assessors with different types
of health education) and high internal consistency values
(Cronbach’s α >0.8) [33]. There is a Swedish version of the
instrument which is available and widely used but no pub-
lished data on validity were found. The internal consistency
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was satisfactory in the dataset as evidenced by a Cronbach’s
alpha of 0.83.
Statistics
Participant characteristics and prevalence of symptoms
were explored using descriptive statistics. To test rela-
tionships between resident characteristics (sex, cognitive
function, ADL-capacity, type of unit and length of stay)
and the prevalence of symptoms (pain and neuropsychi-
atric symptoms), chi-square tests for independence with
Yates’ continuity correction were used with the φ coeffi-
cient as the effect size measure. A Yates’ continuity cor-
rection was performed as chi-square tests are biased
upwards in 2 × 2 contingency tables. An upwards bias
tends to make the result more significant than it should
be. To account for the increased risk of making type 1
errors when performing multiple tests, differences were
regarded as being statistically significant when p-values
were <0.01 (instead of the more commonly used 0.05).
The φ-coefficient >0.1 was used based on criteria sug-
gested by Cohen [34].
For the analyses, scores on the Gottfries’ cognitive
scale, P-ADL, PAINAD, NPI-NH and resident length of
stay were coded into dichotomous variables. The Gott-
fries’ cognitive scores were dichotomized in two groups
where a score of 0–23 indicates a cognitive impairment
equal to dementia, and a score of 24–27 indicates being
cognitively intact [14, 27]. The ADL index was dichoto-
mized into scores of 0–3 indicating ADL dependence
and 4–6 indicating ADL independence [35]. The NPI-
NH scores were dichotomized as ‵0′ if symptoms were
not present and ‵1′ if symptoms were present. PAINAD
scores were dichotomized in two groups where a score of
0 or 1 indicates no pain and a score of 2–10 indicates pain
[36]. The sample median length of stay (21.5 months) was
used to determine the shortest and longest length of stay.
To explore the degree of cognitive impairment in the sam-
ple, the Gottfries’ cognitive scores were further divided
into mild cognitive impairment (score 16–23), moderate
cognitive impairment (score 8–15) and severe cognitive
impairment (score 0–7) [37]. Missing data were not re-
placed. All statistical analyses were conducted using Statis-
tical Package for Social Sciences version22 (for Windows;
IBM, Armonk, NY, USA).
Results
A total of 6 902 resident questionnaires were distributed,
and 4 831 were completed and returned, giving an over-
all response rate of 70 %. The 188 participating nursing
home facilities had between 7 and 128 beds and included
both SCU (31 %), and general units (69 %). The staff
who performed proxy assessment of the residents were
mostly female (94 %) and worked as enrolled nurses
(84 %). More than half (58 %) of the staff reported that
they interacted with the resident on a daily, working
basis and the rest reported that they interacted with
resident on a weekly basis (42 %). The resident sample
(N = 4831) contained more female (67.8 %) than male
(32.2 %) residents and the resident age ranged from
47–107 years with a mean age of 85.5 years. The sam-
ple median length of stay was 21.5 months and ranged
from 0–379 months. A minority of residents (17.6 %)
had Swedish as a second language and 37.8 % of the
residents lived in a SCU (Table 1).
The results showed that 66.6 % of residents were rated
as having a cognitive impairment and 56.3 % as being
ADL dependent. In addition, 92 % of the residents were
assessed as presenting neuropsychiatric symptoms. Al-
most half of all residents were rated as having symptoms
of pain (47.9 %). Of the residents with cognitive impair-
ment, 23.6 % were rated as having severe cognitive im-
pairment, 38.6 % moderate impairment and 37.7 % mild
impairment (Table 2). More than half (52.7 %) of the
residents in general units were rated as having a cogni-
tive impairment.
The results also show that the prevalence of pain was
not significantly different between male and female resi-
dents. Pain was more prevalent among residents with
cognitive impairment and those who were ADL-
dependent. There was a significant difference between
SCUs and general units regarding the prevalence of pain
but the effect size was very small, <0.1, and was inter-
preted as unimportant. The prevalence of pain did not
differ significantly between shorter-and longer-stay resi-
dents. The prevalence of neuropsychiatric symptoms did
not differ significantly between resident gender, ADL
Table 1 Sample characteristics
% (n) 95 % CI Missing (n)
Female 67.8 (3239) 66.5–69.1 54
Residing with partner 2.9 (135) 2.4–3.3 99
Single room 94.9 (4534) 94.3–95.6 55
Swedish as first language 82.4 (3844) 81.3–83.5 167
Residing in SCU 37.8 (1778) 36.4–39.1 122
Residing in regular unit 62.2 (2931) 60.9–63.6
ADLs
Showering/Bathing 81.0 (3848) 79.8–82.1 78
Dressing 68.4 (3237) 67.1–69.8 102
Toileting 53.1 (2512) 51.7–54.5 101
Transferring 43.7 (2070) 42.2–45.1 89
Continence 49.1 (2281) 47.7–50.5 185
Eating 15.8 (748) 14.8–16.9 106
Resident age, years (Mean ± SD) 85.5 (7.8) 323
Length of stay, months (Mean ± SD) 30.4 (32.0) 1439
Percentages are in valid percent, N does not add up to 4831 in all variables
due to missing data
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capacity or length of stay. However, significant differ-
ences were found between residents with and without
cognitive impairment and between residents living at
SCUs and general units (Table 3).
Discussion
This study aimed to explore the prevalence of cognitive
impairment, ADL-dependency, pain and neuropsychi-
atric symptoms among residents in a nationally repre-
sentative Swedish sample, and to investigate whether
pain and neuropsychiatric symptoms differ in relation to
gender, cognitive function, ADL-capacity, type of unit
and length of stay. The results found in this study pro-
vide a deeper knowledge about the national prevalence
rates, which could contribute to a greater understanding,
and awareness of the needs of nursing-home residents.
The findings presented in this study are baseline data
that will enable follow-up studies. A longitudinal follow-
up is planned for 2018 and other future national and
international studies can compare those results with the
results from this study. The results show a cognitive im-
pairment prevalence rate of 67 %, which is in line with
earlier studies in similar contexts which indicate preva-
lence rates of 71–73 % [6, 7]. This finding is also in line
with a European study including 4156 residents in eight
countries (the Czech Republic, England, Finland, France,
Germany, Italy, The Netherlands and Israel) which
shows an overall prevalence of cognitive impairment of
68 % [3]. Thus, the results of this study support previous
studies and contribute recent data to the literature con-
cerning cognitive impairment in nursing homes.
The results also show that about 56 % of residents were
ADL-dependent, which is higher than the overall preva-
lence of dependency reported in a previous European
study (40 %) [10]. However, resident ADL capacity was
evaluated using different scales and cannot therefore be
directly compared. Pain was prevalent among almost half
of the residents (48 %), a finding which is congruent with
other European studies showing prevalence rates of 48 %
[10], but lower than a previous Swedish study reporting a
prevalence rate of 57 % [11]. Again, different pain as-
sessment methods were used in these studies which
could help to explain the differences. The results of this
study indicate that the prevalence of pain was higher
among residents with cognitive impairment and among
ADL-dependent residents, but did not differ in relation
to resident gender. These findings are incongruent with
previous findings from a Swedish study showing that
Table 2 Prevalence of pain, cognitive impairment and
neuropsychiatric symptoms
% (n) 95 % CI Missing (n)
ADL dependent 56.3 (2526) 54.9–57.8 347
Pain 47.9 (2103) 46.4–49.4 441
Cognitive impairment 66.6 (2827) 65.2–68.0 586
Mild 37.7 (1067) 36.0–39.5 −
Moderate 38.6 (1092) 36.8–40.4 −
Severe 23.6 (668) 22.1–25.2 −
Neuropsychiatric symptom, any 92.0 (4309) 91.2–92.8 146
Percentages are in valid percent, N does not add up to 4831 in all variables
due to missing data
Table 3 Differences in prevalence of pain and neuropsychiatric symptoms by resident characteristics, type of unit and resident
length of stay
Characteristics, % (n) Pain p E.S. One or more NPS p E.S.
Sex
Male 45.5 (634) 0.038 0.032 91.8 (1371) 0.839 0.004
Female 49.0 (1448) 92.1 (2895)
Cognitive function
Intact 31.0 (407) <0.001 0.237 83.8 (1134) <0.001 0.195
Impaired 56.2 (1475) 95.3 (2650)
ADL capacity
Independent 35.7 (642) <0.001 0.213 88.7 (1676) <0.001 0.096
Dependent 57.2 (1335) 94.1 (2332)
Type of unit
General 44.4 (1191) <0.001 0.093 89.7 (2547) <0.001 0.102
SCU 54.0 (871) 95.4 (1657)
Length of stay, median split
Short 43.9 (693) 0.001 0.059 90.9 (1507) 0.075 0.032
Long 49.7 (785) 92.7 (1537)
Bold text indicates statistically significant differences (p <0.01) with effect size (E.S) of, φ >0.1. NPS neuropsychiatric symptoms, Short <21.5 months,
Long >21.5 months
Björk et al. BMC Geriatrics  (2016) 16:154 Page 5 of 8
the prevalence of pain did not differ in relation to cog-
nitive impairment [11] and that the prevalence was
higher among female residents [14]. The prevalence of
pain in this study can be interpreted as indicating that
further assessment and management of pain could be a
priority in Swedish nursing homes.
This study also showed a high prevalence of cognitive
impairment in regular units (53 %), which can be com-
pared to slightly lower prevalence rates (40 %) reported
in a recent UK study [38]. It has been suggested that de-
mentia continues to be under-diagnosed in general nurs-
ing home units [39–41], an earlier Swedish study, for
example, found that although 71 % of the sample were
assessed as having a cognitive impairment, only 40 %
had a dementia diagnosis [6]. The high prevalence of
cognitive impairment in general units in this study may at
least be partly explained by a reduction in the number of
nursing-home beds in Sweden since the early 2000, and
the associated higher thresholds for nursing-home admis-
sion. As a result of these changes, nursing-home residents
are older and more frail when admitted to nursing homes
today compared to previously [24]. It seems that to facili-
tate person-centred care for residents, further clinical as-
sessments may be appropriate to determine the presence
and type of dementia. Further studies would be valuable.
The results of this study also show that a majority of
the cognitively impaired residents presented with one or
more neuropsychiatric symptoms (95 %), which is
slightly higher than the 89 % found in a previous Dutch
study [20]. In addition to being a biomedical symptom,
neuropsychiatric symptoms have been conceptualized as
reflecting unmet needs, environmental overload and/or
pain [42, 43]. From such a conceptualisation, the inter-
pretation that neuropsychiatric symptoms may indicate
a present underlying condition, such as pain, seems rea-
sonable. Earlier studies have shown that increased pain
treatment reduced neuropsychiatric symptoms [44–46].
Non-pharmacological interventions to manage neuro-
psychiatric symptoms are an essential part of contem-
porary geriatric and gerontological care in nursing
homes, recommended by a wide range of national and
international medical organizations and expert groups
[47]. Such non-pharmacological interventions include
environmental adjustments and person-centred activities
tailored to meet residents’ needs and enhance quality of
life. Very few studies have been found on the extent to
which residents can participate in non-pharmacological
interventions and activities in Swedish nursing homes
[48], and to what extent participation in such interven-
tions and activities is related to residents’ quality of life
and thriving. In addition, results from a Swedish study
in SCUs stresses that residents’ engagement in everyday
activities was very low and that residents participating in
such activities lived in more person-centred units and
had a higher quality of life [48]. Further studies explor-
ing the extent to which residents are engaged in non-
pharmacological interventions and activities, and how
this associates with indicators of wellbeing, would be
valuable. Differences in the prevalence of neuropsychi-
atric symptoms have previously been described between
males and females and in relation to level of cognitive
impairment. In this study, the prevalence of neuro-
psychiatric symptoms did not differ significantly between
resident genders, ADL capacity or length of stay. Signifi-
cant differences were found between SCU and regular
units, a finding that could be expected considering that
the residents in the former have a cognitive impairment.
Relevance for clinical practice, education and future
research
Knowledge about the prevalence of symptoms and the re-
lationships between neuropsychiatric symptoms, pain and
various resident characteristics, as found in this study,
could be of value in the education of students, nursing-
home staff and other professions in the field. The study
provides nursing-home staff and researchers with an
awareness of assessment scales that could be used clinic-
ally to provide more structured evaluations, plans and tar-
geted improvements in care. The results could also be of
value as a point of reference for future national and inter-
national research studies.
Limitations
The cross-sectional data used in this study limit the pos-
sibilities for causal inference. The findings presented are
baseline data enabling the conduct of follow-up studies.
Longitudinal studies are planned, the next one in 2018.
Repeated longitudinal measures will allow the explor-
ation of trends, changes over time and assessments of
the impact of changes and interventions on a population
level. Proxy-rating resident symptoms may also be con-
sidered a limitation of this study. However, this proced-
ure was deliberately chosen because of the suspected,
and later confirmed, high prevalence of cognitive impair-
ment in the sample which could have compromised self-
reporting. The fact that the assessors did not receive any
training in assessment is a weakness of the study. How-
ever, the staff received written instructions about how to
carry out the assessments. Furthermore, the assessments
of residents were performed by the member of staff who
knew each particular resident best, so as to increase the
validity of ratings. This meant that all ratings were based
on extensive personal knowledge of residents, together
with the professional clinical skill of direct-care staff,
safeguarding the high quality of the data. Perhaps a limita-
tion that applies not to this study but more to comparative
research overall, is the fact that different studies have used
different methods to assess common symptoms. This
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means that differences in the prevalence of cognitive im-
pairment, pain, and/or neuropsychiatric symptoms be-
tween this and other studies is likely to be influenced by
the use of different measuring methods. Further national
and international consensus statements (e.g. Moniz-Cook
2008) would be valuable [49]. There is no previously pub-
lished data on validity of the Swedish language version of
the PAINAD scale used in this study, which may impact
the validity of the present pain ratings. Further validation
estimates would be valuable.
Conclusions
The prevalence rates ascertained in this study could con-
tribute to a greater understanding of the needs of nursing-
home residents, and may provide nursing-home staff and
managers with trustworthy assessment scales and bench-
mark values for further quality assessment purposes,
clinical development work and initiating future nursing
assessments. In addition, the findings could prove helpful
regarding questions regarding the financing and planning
the care on a national level, and also be valuable to stake-
holders and organizations.
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